Literature DB >> 21858273

Click maltose as an alternative to reverse phase material for desalting glycopeptides.

Juan Li1, Xiuling Li, Zhimou Guo, Long Yu, Lijuan Zou, Xinmiao Liang.   

Abstract

Desalting peptides before mass spectrometry analysis is important because salts lead to adduct formation, increased chemical noise and ion suppression effect. A high concentration of salt can clog nanoelectrospray ionization (ESI) emitters. The reverse phase C18 material is commonly used to desalt peptides because of its high binding capacity. However, peptides with high hydrophilicity, such as glycopeptides, are not retained well on this material, resulting in the loss of peptide information. To improve the efficiency of glycopeptide desalting, we introduced a hydrophilic interaction chromatography (HILIC)-based material named click maltose. Four glycoproteins, horseradish peroxidase (HRP), human serum immunoglobulin G (IgG), bovine ribonuclease B (RNase B), and α-1 acid glycoprotein (AGP) were chosen as models and their glycopeptides were desalted with click maltose, AQ C18, Empore C18 and ZipTip C18. Click maltose as a HILIC material exhibited better performance than the other three C18 materials for both number of targeted glycopeptides and their corresponding intensities. In addition, accurate glycopeptide profiling was achieved with click maltose desalting regardless of peptide lengths and glycan types.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858273     DOI: 10.1039/c1an15362e

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  2 in total

Review 1.  Oligosaccharide analysis by mass spectrometry: a review of recent developments.

Authors:  Muchena J Kailemia; L Renee Ruhaak; Carlito B Lebrilla; I Jonathan Amster
Journal:  Anal Chem       Date:  2013-12-16       Impact factor: 6.986

2.  Selective enrichment of sialylated glycopeptides with a d-allose@SiO2 matrix.

Authors:  Na Sun; Yuting Xiong; Guangyan Qing; Yanyan Zhao; Xiuling Li; Xinmiao Liang
Journal:  RSC Adv       Date:  2018-11-19       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.